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Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
(CADASIL) is a rare hereditary small vascular disease and its mainly clinical manifestations are ischemic events.
Spontaneous intracerebral hemorrhage (ICH) involvement in patients with CADASIL is extremely uncommon.
Case report: A 46-year-old normotensive Chinese man developed a large hematoma in the left basal ganglia after
he was diagnosed with CADASIL 2 months ago, the patient did not take any antithrombotics. Susceptibility weighted
imaging at pre-ICH showed multiple cerebral microbleeds (CMBs) in the bilateral basal ganglia. He experienced
migraine at about 10 months post-ICH. To our knowledge, this is the first report of ICH in CADASIL patients with
Arg90Cys mutation in exon 3.
Discussion and conclusions: ICH should be considered when evaluating new attacks in CADASIL patients. Thus, MRI
screening for CMBs might be helpful in predicting the risk of ICH and guiding antithrombotic therapy. In addition, strict
control of hypertension and cautious use of antithrombotics may be important in this context.
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Cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL) is a rare
hereditary, autosomal dominant, cerebral small vessel
disease caused by mutations in the NOTCH3 gene [1]. The
disease is clinically characterized by migraine, subcortical
ischemic events, psychiatric disorders, and cognitive
impairment eventually leading to dementia and disability
[2,3]. The accumulation of granular osmiophilic material
(GOM) in arterial walls on ultrastructural examination
is pathognomonic. Typical abnormalities on magnetic
resonance imaging (MRI) in CADASIL include severe
leukoencephalopathy accentuated in the temporal poles
and multiple subcortical lacunar infarcts. CADASIL has
been considered a primarily ischemic form of cerebral
vascular disorder, spontaneous intracerebral hemorrhage
(ICH) in CADASIL is rarely reported. The exact mecha-
nisms of ICH in this setting are unknown currently. Here
we report a middle-aged Chinese male with CADASIL
who developed a large ICH during the disease process.* Correspondence: zhusuiqiang@gmail.com
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in any medium, provided the original work is pAs far as we know, this is the first report of ICH in
patients carrying the Arg90Cys mutation in exon 3 of the
NOTCH3 gene. We also briefly reviewed the literature on
this topic.Case presentation
On 22nd March 2012, a 46-year-old right-handed Chinese
male, who had been misdiagnosed with multiple sclerosis
three years earlier in another hospital because of the
white matter lesions in MRI, came into the hospital due
to sudden dysarthria and left hemiparesis. His blood
pressure was 130/80 mmHg and his temperature was
36.6˚C. A neurological examination revealed left hemipar-
esis, dysarthria, spasticity in his extremities and diffuse
brisk deep tendon reflexes, corresponding to a diagnosis
of pure motor stroke [4]. Mini-mental status examination
was normal (a score of 28 out of 30).
An acute subcortical infarction was found in the right
basal ganglia and periventricular areas on the 2nd day of
hospitalization (Figure 1A, 1B). There was no significant
stenosis or malformation of major cerebral arteries on
MR angiography (Figure 1C). MRI confirmed the severe
white matter lesions concentrated around the periventricu-
lar, pons, external capsule and the anterior temporal pole
and multiple subcortical lacunar infarcts (Figure 1D-1F).
Some cerebral microbleeds (CMBs) were also present inOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 MRI findings. A-B. Diffusion-weighted imaging shows an acute cerebral infarct on the right basal ganglia and periventricular areas.
C. MR angiography reveals no significant stenosis or malformation of major cerebral arteries. D-F. FLAIR image demonstrates hyperintensity lesions
in the periventricular white matter, basal ganglia, and brainstem, characteristically in the external capsule and anterior temporal pole. G. Susceptibility
weighted imaging shows multiple cerebral microbleeds in the bilateral basal ganglia.
Lian et al. The Journal of Headache and Pain 2013, 14:98 Page 2 of 6
http://www.thejournalofheadacheandpain.com/content/14/1/98the bilateral basal ganglia and subcortical areas (Figure 1G).
There was no evidence for head trauma, cavernous
hemangioma, arteriovenous malformations, aneurysms
or neoplasia. In the past, he did not have any episodes
of migraine and any vascular risk factors other than
smoking. His family history disclosed that his brother had
a similar episode of dysarthria. Blood tests, including a
complete blood cell count, glucose, cholesterol, creatinine,
erythrocyte sedimentation rate, homocysteine, and C-
reactive protein were normal. Hemocoagulation tests
were within normal values. Coagulation factors such
as factor II, V, VII, VIII, IX and von Willebrand factor
were normal. Serological tests for collagen disease
were unremarkable, as was the cerebrospinal fluid test-
ing. Lactate and pyruvate levels were normal in blood.
Urine analysis was normal with no proteinuria. Cocaine
urine test was negative. An echocardiogram was nor-
mal, and electrocardiographic monitoring did not show
arrhythmias.
Since CADASIL was suspected based on the charac-
teristic MRI findings and his family history, a skin biopsy
and NOTCH3 gene analysis was performed on hospital day
13 after the informed consent. Ultrastructural examinationshowed the accumulation of GOM in small arterial walls
(Figure 2A). NOTCH3 gene testing revealed a heterozygote
Arg90Cys mutation in exon 3 (Figure 2B). The patient
remained normotensive throughout his hospital stay. He
was not given any antithrombotics because of gastric
hemorrhage 1 year ago. The modified Rankin scale (mRS)
score at 30 days after this ictus was 1 point.
Two months after discharge, he was admitted again to
our hospital with a sudden unresponsiveness. Initial blood
pressure was 138/98 mmHg and neurological examination
showed mild coma and right spastic hemiplegia. The
admission Glasgow Coma Scale score and NIH Stroke scale
(NIHSS) score was 11 and 20 respectively. An immediate
computed tomography (CT) scan demonstrated an acute
ICH in the left basal ganglia extending into the ventricular
system (Figure 3A). There was no evidence of trauma on
head CT. Follow-up CT three days later showed no sig-
nificant change of hematoma size (Figure 3B). The patient
showed gradual recovery from his right hemiplegia with-
out hematoma evacuation. The 30-day Barthel index and
NIHSS score after ICH was 45 and 14 respectively. Then,
the patient had an mRS of 2 at 12 months after ICH on-
set, supporting a favorable outcome. In addition, the
Figure 2 Ultrastructural examination and NOTCH3 gene testing. A. GOM deposits (arrows) are located in the basement membrane of
smooth muscle cells. B. Gene analysis indicates a mutation CGT→ TGT in codon 90 in exon 3 of the NOTCH3 gene.
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second hospital admission.
Discussion
This study supports the growing evidence for both ischemic
and hemorrhagic events in CADASIL, thus expanding
its clinical phenotype. MRI screening for CMBs might be
helpful to predict the risk of ICH and guide antithrombotic
therapy in patients with CADASIL. To our knowledge, this
is the first report of ICH in CADASIL patients harboringFigure 3 Head CT scan at the second admission. A. An acute irregular large
effect, which extended into the ventricular system. B. CT scans three days later san Arg90Cys mutation in exon 3 of the NOTCH3 gene on
chromosome 19.
The development of ICH in patients with CADASIL is
extremely rare. As shown in Table 1, there were only 21
reported cases with adequate clinical and genetic data
[5-14]. The mean age of these patients was 56.0 ± 13.4 years.
Hypertension was present in 16 patients (72.7%). Twelve
patients (54.5%) received antithrombotics to prevent ischemic
events. ICH was the initial manifestation in 7 patients.
The most frequent site of ICH was the basal ganglia. Thehematoma presents near the left basal ganglia with a prominent mass
how no significant change of the size of hematoma.








of CMBsExon Amino acid
Werbrouck [5] M/45 HT, HC Migraine, CI, ICH NA Basal ganglia 4 R182C 6
Oh [6] M/39 Smoking, HT, alcohol CI, ICH Anticoagulant
and statins
Temporal lobe 11 R544C NA
Sano [7] M/46 Smoking CI,Dementia, ICH Antiplatelet Putamen 6 A332C NA
Maclean [8] M/56 Smoking, alcohol CI, ICH Antiplatelet Frontal lobe 4 R133C 1
Choi [9,18] F/68 HT TIA, Dementia, ICH Antiplatelet (3) Cerebellum 11 R578C 27
M/69 HT,DM Dementia, ICH Thalamus
Parietal lobe
11 R544C 85
M/61 HT, alcohol ICH, Headache Basal ganglia 11 R544C 14
M/48 HT ICH, TIA Basal ganglia 11 R544C 5
F/86 HT, HC Headache, ICH
Gait difficulty
Thalamus NA NA 32
Lee [10] M/43 HT Gait difficulty, CI, ICH Antiplatelet(5) Thalamus 4 R133C NA
F/56 HT ICH Thalamus 11 R544C NA
M/57 HT CI, ICH Temporal lobe 11 R544C NA
M/56 HT CI, ICH Putamen,
Parietal lobe
11 R544C NA
M/35 HT Gait difficulty, ICH Putamen 11 R544C NA
Ragoschke-Schumm [11] F/47 HT CI, ICH NA Cerebellum NA NA 25
Pradotto [12] M/65 NA Dementia, ICH Anticoagulant Frontal lobe 13 A680G 3
Kotorii [13] F/72 NA Gait difficulty,
CI Dementia, ICH
NA Temporal lobe 18 G975C NA
Rinnoci [14] M/54 HT ICH NA Basal ganglia 22 A1231C 25
F/67 HT, Smoking ICH NA Basal ganglia 22 A1231C 3
M/77 HT, Smoking ICH, Dementia NA Basal ganglia 14 A728C 2
M/39 HC, DM SAH NA Interpeduncular
cistern
24 C1298P 25
This M/46 Smoking CI,ICH Statins Basal ganglia 3 A90C 18
ICH,intracerebral hemorrhage; CMBs,cerebral microbleeds; HT,hypertension; DM,diabetes mellitus; HC,hypercholesterolemia; CI, cerebral infarctionr; TIA, transient
ischemic attack; SAH, subarachnoid hemorrhage; NA, not available.
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(range 1 to 85). R544C mutation in exon11 was prevalent
(45.0%).
CMBs were frequently detected on MRI in CADASIL
patients. Growing evidence showed CMBs may indicate
a risk of ICH or even predict the occurrence of ICH
[15-17]. CADASIL was characterized by the depositions
of GOM in vascular smooth muscle cells, thus making the
arteries more bleed-prone. Choi et al. recently found that
the CADASIL patients with hypertension had a significantly
higher prevalence of cerebral infarction and ICH and
significantly greater numbers of CMBs than without
hypertension [18]. Both CMBs and ICH in this reported
case were located in the basal ganglia, the most frequent
site of hypertensive ICH. Thus, the cause of ICH in this
patient may be the additional effect of abrupt fluctuationof blood pressure on the fragile arterioles. Strict control of
blood pressure may be crucial in such context, particularly
in the presence of CMBs.
The onset of ICH seemed to be associated with specific
mutation or the use of antithrombotics. The prevalent
occurrence of R544C mutation (45.0%) in this analysis
potentially suggested an association between ICH and
the genetic mutation. However, previous data showed
no relation between genotype and clinical phenotype
[3]. Recent studies also warned for the increased risk of
ICH by taking antithrombotic agents in CADASIL patients
[6,9-11]. In this report, more than 54% of the patients
received antithrombotic therapy to prevent ischemic
events. However, Choi JC et al. recently reported that
the previous antiplatelet use had no contribution to the
occurrence of ICH in patients with R544C mutation [18].
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carefully be weighed when treating CADASIL patients.
MRI screening for CMBs may be helpful in this risk
stratification [16,17]. Taking into account the high mor-
bidity and mortality of ICH and lack of proven treatment
of CADASIL, routine use of aspirin or anticoagulants
to prevent recurrent ischemic stroke might be unneces-
sary. On the contrary, cilostazol may be an alternative to
aspirin in such context due to its efficacy and low risk of
hemorrhage [19].
We presented a clinical note reporting the case of a
middle-aged Chinese man with ICH two months after a
pure motor stroke due to acute small subcortical ischemic
stroke in CADASIL. The reported patient almost com-
pletely improved at 30 days after the first admission. Re-
cently, a clinical study reported that patients with pure
motor stroke showed significant improvement with a
higher ratio of symptom free at hospital discharge than
patients with non-lacunar stroke [4]. In addition, this re-
port might help to elucidate the course of improvement
after ICH. The patient showed profound improvement
from severe disability at the second hospital discharge
to a favorable long-term outcome at 12 months post-
ICH. Arboix et al. recently documented that the site of
hematoma had an impact on the early outcome in
patients with ICH [20]. Thus, whether ICH clinical
trials should use a longer duration of follow-up should
be considered and may potentially be influenced by the
specific site of ICH.
It is very important to separate CADASIL from other
potential mimickers such as mitochondrial encephalomy-
opathy lactic acidosis and stroke-like episodes (MELAS) or
Fabry disease. MELAS is associated with a mutation in
the mitochondrial tRNA gene. The typical findings in
MRI are bilateral, parieto-occipital, transterritorial is-
chemic lesions. To the best of our knowledge, only 3
patients with ICH were reported among MELAS syndrome
[21]. Fabry disease is a rare X-linked inherited disorder
of glycosphingolipid metabolism because of deficient
or absent lysosomal α-galactosidase A activity [22]. Its
classical manifestations include neuropathic pain, skin
lesion and gastrointestinal symptoms, progressive renal and
cardiac insufficiency and stroke [22]. Females seemed to
be more likely to develop a stroke. In addition, the disease
was frequently associated with ischemic stroke.
To date, it is yet to be ascertained whether ICH in
CADASIL occurred as a disease process associated
with genetic mutation or as a result of hypertension
and CMBs or whether it was due to the administration
of specific antithrombotics. The combination of these
factors may be more prone to the onset of ICH. Future
studies should investigate the underlying mechanisms
of ICH and guide the stroke prevention in patients with
CADASIL.Conclusions
ICH should be considered when assessing new events in
patients with CADASIL. The mechanisms of ICH might
result from the combination of genic mutation and
vascular risk factors. Taking into account the risk of
ICH, MRI screening for CMBs may be helpful for risk
stratification. In addition, stringent control of these modi-
fied factors, especially hypertention and cautious use of
antithrombotics may be pivotal in CADASIL patients.
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